Simplex Trading, LLC Alaunos Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.43 - $0.65 $2,142 - $3,238	4,982 Added 54.58%	14,110 $7,000
Q1 2023 Apr 27, 2023	SELL	$0.46 - $0.81 $17,849 - $31,431	-38,804 Reduced 80.96%	9,128 $5,000
Q4 2022 Feb 02, 2023	BUY	$0.5 - $261.0 $15,421 - $8.05 Million	30,842 Added 180.47%	47,932 $31,000
Q3 2022 Nov 04, 2022	SELL	$1.04 - $322.5 $3,779 - $1.17 Million	-3,634 Reduced 17.54%	17,090 $29,000
Q2 2022 Aug 03, 2022	SELL	$0.41 - $1.24 $22,126 - $66,920	-53,968 Reduced 72.25%	20,724 $25,000
Q1 2022 May 02, 2022	BUY	$0.62 - $1.17 $26,115 - $49,281	42,121 Added 129.32%	74,692 $48,000
Q4 2021 Feb 23, 2022	SELL	$1.09 - $1.89 $61,853 - $107,249	-56,746 Reduced 63.53%	32,571 $35,000
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $16,014 - $22,346	6,089 Added 7.32%	89,317 $235,000
Q1 2021 Apr 26, 2021	BUY	$2.82 - $5.6 $118,693 - $235,703	42,090 Added 102.31%	83,228 $299,000
Q4 2020 Feb 02, 2021	SELL	$2.09 - $3.09 $9,030 - $13,351	-4,321 Reduced 9.51%	41,138 $103,000
Q3 2020 Oct 14, 2020	SELL	$2.39 - $3.43 $78,838 - $113,145	-32,987 Reduced 42.05%	45,459 $114,000
Q2 2020 Jul 13, 2020	BUY	$2.2 - $3.71 $70,738 - $119,291	32,154 Added 69.46%	78,446 $257,000
Q1 2020 Apr 29, 2020	BUY	$1.9 - $4.98 $12,722 - $33,346	6,696 Added 16.91%	46,292 $113,000
Q4 2019 Feb 05, 2020	BUY	$3.95 - $5.35 $119,475 - $161,821	30,247 Added 323.53%	39,596 $186,000
Q3 2019 Oct 15, 2019	SELL	$4.13 - $6.94 $171,233 - $287,739	-41,461 Reduced 81.6%	9,349 $40,000
Q2 2019 Jul 26, 2019	BUY	$3.98 - $6.2 $39,784 - $61,975	9,996 Added 24.49%	50,810 $296,000
Q1 2019 Apr 18, 2019	BUY	$2.0 - $4.4 $11,990 - $26,378	5,995 Added 17.22%	40,814 $0
Q4 2018 Jan 16, 2019	SELL	$1.61 - $3.62 $46,474 - $104,494	-28,866 Reduced 45.33%	34,819 $65,000
Q3 2018 Oct 23, 2018	SELL	$2.26 - $3.27 $1,468 - $2,125	-650 Reduced 1.01%	63,685 $203,000
Q2 2018 Jul 30, 2018	SELL	$3.02 - $4.94 $69,142 - $113,101	-22,895 Reduced 26.25%	64,335 $194,000
Q1 2018 Apr 26, 2018	BUY	$3.46 - $5.14 $218,353 - $324,375	63,108 Added 261.62%	87,230 $341,000
Q4 2017 Jan 10, 2018	SELL	$4.0 - $6.54 $29,800 - $48,723	-7,450 Reduced 23.6%	24,122 $99,000
Q3 2017 Oct 25, 2017	BUY	$4.99 - $6.57 $157,544 - $207,428	31,572	31,572 $193,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $398M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account